Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms
Sean Manning, … , Andrea Pucci, Rachel L. Batterham
Sean Manning, … , Andrea Pucci, Rachel L. Batterham
Published March 2, 2015
Citation Information: J Clin Invest. 2015;125(3):939-948. https://doi.org/10.1172/JCI76305.
View: Text | PDF
Review Series

Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms

  • Text
  • PDF
Abstract

Bariatric surgery is the most effective treatment for severe obesity, producing marked sustained weight loss with associated reduced morbidity and mortality. Roux-en-Y gastric bypass surgery (RYGBP), the most commonly performed procedure, was initially viewed as a hybrid restrictive-malabsorptive procedure. However, over the last decade, it has become apparent that alternative physiologic mechanisms underlie its beneficial effects. RYGBP-induced altered feeding behavior, including reduced appetite and changes in taste/food preferences, is now recognized as a key driver of the sustained postoperative weight loss. The brain ultimately determines feeding behavior, and here we review the mechanisms by which RYGBP may affect central appetite-regulating pathways.

Authors

Sean Manning, Andrea Pucci, Rachel L. Batterham

×

Figure 1

Schematic diagram illustrating the mechanisms involved in regulating feeding behavior.

Options: View larger image (or click on image) Download as PowerPoint
Schematic diagram illustrating the mechanisms involved in regulating fee...
Nutrient entry into the GI tract causes stomach and intestine distension, secretion of pancreatic enzymes and bile acids, altered enteric and vagal nerve signaling, and exposure of gut enteroendocrine cells to nutrients, with altered circulating gut hormone levels (e.g., decrease in orexigenic hormone ghrelin and increase in anorectic hormones PYY3-36 and GLP-1). Gut-derived signals (nutrient, hormonal, and neural) and adipokines (e.g., leptin, IL-6, TNF-α, and adiponectin) act directly and indirectly upon brainstem and hypothalamic arcuate nuclei (first order neurons: orexigenic NPY/AgRP and anorexigenic POMC/CART). ARC neurons interact with second order neurons in the PVN, which influence the thyroid and adrenal hormonal axes, and in the LHA. Altered brainstem and hypothalamic activation influence brain reward and higher cognitive brain regions and together lead to altered feeding behavior. Abbreviations: ACTH, adrenocorticotrophic hormone; AgRP, agouti-related peptide; ARC, arcuate nucleus; AVP, vasopressin; CART cocaine and amphetamine-regulated transcript; CRH, corticotropin-releasing hormone; ENS, enteric nervous system; FGF-19, fibroblast growth factor 19; LHA, lateral hypothalamic area; MSH, melanocortin-stimulating hormone; NPY, neuropeptide Y; POMC, pro-opiomelanocortin; NT, neurotensin; OREX, orexin; OT, oxytocin; PVN, paraventricular nucleus; TRH, thyrotropin-releasing hormone; TSH, thyroid-stimulating hormone; PNS, peripheral nervous system; SNS, sympathetic nervous system; ACTH, adrenocorticotrophic hormone, ENS, enteric nervous system.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts